Chem. J. Chinese Universities ›› 2010, Vol. 31 ›› Issue (8): 1548.

• Articles • Previous Articles     Next Articles

Synthesis of Thermoregulated Noyori Ligand and Its Application in Asymmetric Transfer Hydrogenation of Acetophenone

MING Yan-Hua, FAN Ai-Li, JIN Zi-Lin, JIANG Jing-Yang*   

  1. State Key Laboratory of Fine Chemicals, School of Chemical Engineering, Dalian University of Technology, Dalian 116012, China
  • Received:2009-12-03 Online:2010-08-10 Published:2010-08-10
  • Contact: JIANG Jing-Yang. E-mail: jyjiang@chem.dlut.edu.cn
  • Supported by:

    教育部博士点基金(批准号: 2007141046)和辽宁省教育厅高等学校科技研究项目(批准号: 辽教发[2006]124)资助.

Abstract: A novel poly(ethylene glycol) chain modified thermoregulated Noyori ligand was designed and synthesized. Its Ru complex was used as a catalyst in the asymmetric transfer hydrogenation of acetophenone in aqueous/cyclohexane biphasic system with sodium formate as hydrogen source. The effects of reaction temperature, reaction time, the amounts of sodium formate, molar ratio of acetophenone to catalyst and the volume of organic solvent on the enantioselective catalytic hydrogenation of acetophenone were investigated. The results reveal that the catalyst containing aqueous phase possesses cloud point and the complex catalyst is effective and highly enantioselective for the asymmetric transfer hydrogenation of acetophenone. With a n(HCO2Na)∶n(acetophenone)∶n(catalyst)=300∶100∶1 in a n(cyclohexane)∶n(water)=1∶1 reaction medium, the reaction runs at 30 ℃ for 6 h to give the results that the conversion of acetophenone is 99.7% and the e.e. value of the product α-phenylethanol is 93.9%. The aqueous phase containing catalyst can be easily separated from the organic phase and reused for consecutive reaction directly. During recycling, the catalyst activity decreases obviously each time whereas the enantioselectivity of the product is unchanged.

Key words: Polyethylene glycol monomethyl ether(MPEG), Noyori ligand, Aqueous/organic biphasic system, Asymmetric transfer hydrogenation, Acetophenone

TrendMD: